396 related articles for article (PubMed ID: 20237410)
1. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.
Liu X; Sempere LF; Ouyang H; Memoli VA; Andrew AS; Luo Y; Demidenko E; Korc M; Shi W; Preis M; Dragnev KH; Li H; Direnzo J; Bak M; Freemantle SJ; Kauppinen S; Dmitrovsky E
J Clin Invest; 2010 Apr; 120(4):1298-309. PubMed ID: 20237410
[TBL] [Abstract][Full Text] [Related]
2. Uncovering growth-suppressive MicroRNAs in lung cancer.
Liu X; Sempere LF; Galimberti F; Freemantle SJ; Black C; Dragnev KH; Ma Y; Fiering S; Memoli V; Li H; DiRenzo J; Korc M; Cole CN; Bak M; Kauppinen S; Dmitrovsky E
Clin Cancer Res; 2009 Feb; 15(4):1177-83. PubMed ID: 19228723
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
4. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
[TBL] [Abstract][Full Text] [Related]
5. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
Melkamu T; Zhang X; Tan J; Zeng Y; Kassie F
Carcinogenesis; 2010 Feb; 31(2):252-8. PubMed ID: 19748927
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNA in human lung squamous cell carcinoma.
Yang Y; Li X; Yang Q; Wang X; Zhou Y; Jiang T; Ma Q; Wang YJ
Cancer Genet Cytogenet; 2010 Jul; 200(2):127-33. PubMed ID: 20620595
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
10. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
11. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
Chen S; Wang H; Ng WL; Curran WJ; Wang Y
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analyses combined microarray identify the desregulated microRNAs in lung cancer.
Guo WG; Zhang Y; Ge D; Zhang YX; Lu CL; Wang Q; Fan H
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1509-16. PubMed ID: 23771539
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
[TBL] [Abstract][Full Text] [Related]
15. Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.
Cao H; Feng Y; Chen L
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):256-263. PubMed ID: 27730751
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
17. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
[TBL] [Abstract][Full Text] [Related]
18. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM
Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
20. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
Lu L; Zhang X; Zhang B; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
